Radiologically isolated syndrome: prognosis and predictors of conversion to multiple sclerosis

Kabaeva A.R.; Boyko A.N.; Kulakova O.G.; Favorova O.O.

doi:https://doi.org/10.17116/jnevro20201200727

Close metadata

Recommended articles:

Results of a 5-year project for the early diagnosis of multiple sclerosis in first-line blood relatives (RADIRS program). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):28-33

Change in the volume of choroidal plexus at the onset of a demyelinating disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):94-99

Magnetic resonance imaging and PET/CT with 11C-methionine for primary central nervous system vasculitis. Burdenko's Journal of Neurosurgery. 2024;(6):71-76

Brain microstructural abnormalities assessed by diffusion kurtosis MRI in patients with focal temporal lobe epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):171-177

Features of the temporomandibular joint morphology and function in the adults with different growth patterns. Stomatology. 2025;(1):29-36

FA2H gene-associated spastic paraplegia (SPG35) — familial case with late onset. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):137-144

MR imaging of cytotoxic lesion of the corpus callosum during pneumonia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):140-144

Abstract:

Increased sensitivity and availability of magnetic resonance imaging (MRI) in neurological routine practice led to the fact that more and more experts began to encounter changes typical for multiple sclerosis (MS) according to MRI in the absence of anamnestic and clinical indications of damage to the central nervous system (CNS). This nosological form has been defined as a radiologically isolated syndrome (RIS). More and more RIS cases convert to MS (up to 30% in the first 5 years after RIS diagnosis). At the moment, there are no biological markers that allow combining RIS and MS into one pathological process and early treatment with disease-modifying drugs (DMT). Prospective studies are actively being conducted to identify demographic, clinical, neuroimaging and biochemical conversion predictors. The identification of the molecular biological RIS features, combining these changes with MS, is an urgent scientific task and will allow timely initiation of therapy of the pathological process already at the subclinical stage.

Keywords:

radiologically isolated syndrome

early multiple sclerosis

MRI

oligoclonal bands

Authors:

Kabaeva A.R.

Pirogov Russian National Research Medical University

SPIN RSCI: 3952-3519
Scopus AuthorID: 57195808362
ORCID: 0000-0002-0982-8520

Boyko A.N.

Pirogov Russian National Research Medical University;
Federal Center of Brain and Neurotechnologies

SPIN RSCI: 9921-9109
Scopus AuthorID: 7102247663
ORCID: 0000-0002-2975-4151

Kulakova O.G.

Pirogov Russian National Research Medical University

ORCID: 0000-0002-5321-3101

Favorova O.O.

Pirogov Russian National Research Medical University

ORCID: 0000-0002-5271-6698

Received:

14.05.2020

Accepted:

18.05.2020

Close metadata

References:

Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple sclerosis. Rev Neurol (Paris). 2016;172(1):3-13. https://doi.org/10.1016/j.neurol.2015.10.006
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. https://doi.org/10.1002/ana.22366
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. https://doi.org/10.1016/S1474-4422(17)30470-2
De Stefano N, Giorgio A, Tintoré M, Pia Amato M, Kappos L, Palace J, Yousry T, Rocca MA, Ciccarelli O, Enzinger C, Frederiksen J, Filippi M, Vrenken H, Rovira À; MAGNIMS study group. Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations. Mult Scler. 2018;24(2):214-221. https://doi.org/10.1177/1352458517717808
Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, Keegan BM, Donlon S, Hua le H, Vidal-Jordana A, Montalban X, Rovira A, Tintoré M, Amato MP, Brochet B, de Seze J, Brassat D, Vermersch P, De Stefano N, Sormani MP, Pelletier D, Lebrun C; Radiologically Isolated Syndrome Consortium (RISC); Club Francophone de la Sclérose en Plaques (CFSEP). Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One. 2014;9(3):e90509. https://doi.org/10.1371/journal.pone.0090509
Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, Hauser SL, Pelletier D. Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome. Neurology. 2009;72(9):800-805. https://doi.org/10.1212/01.wnl.0000335764.14513.1a
Forslin Y, Granberg T, Jumah AA, Shams S, Aspelin P, Kristoffersen-Wiberg M, Martola J, Fredrikson S. Incidence of radiologically isolated syndrome: a population-based study. AJNR Am J Neuroradiol. 2016;37(6):1017-1022. https://doi.org/10.3174/ajnr.A4660
Gabelic T, Ramasamy DP, Weinstock-Guttman B, Hagemeier J, Kennedy C, Melia R, Hojnacki D, Ramanathan M, Zivadinov R. Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis. AJNR Am J Neuroradiol. 2014;35(1):106-112. https://doi.org/10.3174/ajnr.A3653
Lebrun-Frenay C, Kantarci O, Siva A, Cara-Dallière C, Louapre C, Durand-Dubief F, Thouvenot E, Vemersch P, Inglese M, De Stefano N, Mathey G, Le page E, Uygunoğlu U, Tintore M, Laplaud D, De Seze J, Ciron J, Pelletier J, Brochet B, Berger E, Bensa C, Bourre B, Casez O, Mondot L, Zeydan B, Cohen M, Azevedo C, Makhani N, Sormani MP, Pelletier D, Okuda D, RISC, SFSEP, OFSEP. Radiologically isolated syndrome: A 10-year follow-up study to identify factors predicting a clinical event. Multiple Sclerosis Journal. 2019;25(2 suppl):123-130. https://doi.org/10.1177/1352458519868070
Kantarci OH, Lebrun C, Siva A, Keegan MB, Azevedo CJ, Inglese M, Tintoré M, Newton BD, Durand-Dubief F, Amato MP, De Stefano N, Sormani MP, Pelletier D, Okuda DT. Primary progressive multiple sclerosis evolving from radiologically isolated syndrome. Ann Neurol. 2016;79(2):288-294. https://doi.org/10.1002/ana.24564
Kantarci O, Siva A, Eraksoy M, Karabudak R, Sütlaş N, Ağaoğlu J, Turan F, Ozmenoğlu M, Toğrul E, Demirkiran M. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology. 1998;51(3):765-772. https://doi.org/10.1212/wnl.51.3.765
Labiano-Fontcuberta A, Benito-León J. Radiologically isolated syndrome should be treated with disease-modifying therapy — No. Mult Scler. 2017;23(14):1820-1821. https://doi.org/10.1177/1352458517726385
Okuda DT. Radiologically isolated syndrome should be treated with diseasemodifying therapy — Yes. Mult Scler. 2017;23(14):1818-1819. https://doi.org/10.1177/1352458517729462
Makhani N, Lebrun C, Siva A, Brassat D, Carra Dallière C, de Seze J, Du W, Durand Dubief F, Kantarci O, Langille M, Narula S, Pelletier J, Rojas JI, Shapiro ED, Stone RT, Tintoré M, Uygunoglu U, Vermersch P, Wassmer E, Okuda DT, Pelletier D. Radiologically isolated syndrome in children: clinical and radiologic outcomes. Neurol Neuroimmunol Neuroinflamm. 2017;4(6):e395. https://doi.org/10.1212/NXI.0000000000000395
Lebrun C, Le Page E, Kantarci O, Siva A, Pelletier D, Okuda DT; Club Francophone de Sclerose en Plaques (CFSEP); Radiologically Isolated Syndrome Consortium (RISC) Group. Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort. Mult Scler. 2012;18(9):1297-1302. https://doi.org/10.1177/1352458511435931
Labiano-Fontcuberta A, Martínez-Ginés ML, Aladro Y, Ayuso L, Mitchell AJ, Puertas-Martín V, Cerezo M, Higueras Y, Benito-León J. A comparison study of cognitive deficits in radiologically and clinically isolated syndromes. Mult Scler. 2016;22(2):250-253. https://doi.org/10.1177/1352458515591072
Labiano-Fontcuberta A, Benito-Leon J. Radiologically isolated syndrome: An update on a rare entity. Mult Scler. 2016;22:1514-1521. https://doi.org/10.1177/1352458516653666
Lebrun C1, Blanc F, Brassat D, Zephir H, de Seze J; CFSEP. Cognitive function in radiologically isolated syndrome. Mult Scler. 2010;16(8):919-925. https://doi.org/10.1177/1352458510375707
Amato MP, Hakiki B, Goretti B, Rossi F, Stromillo ML, Giorgio A, Roscio M, Ghezzi A, Guidi L, Bartolozzi ML, Portaccio E, De Stefano N; Italian RIS/MS Study Group. Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology. 2012;78(5):309-314. https://doi.org/10.1212/WNL.0b013e31824528c9
Zipoli V, Goretti B, Hakiki B, Siracusa G, Sorbi S, Portaccio E, Amato MP. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler. 2010;16(1):62-67. https://doi.org/10.1177/1352458509350311
Yamout B, Al Khawajah M. Radiologically isolated syndrome and multiple sclerosis. Mult Scler Relat Disord. 2017;17:234-237. https://doi.org/10.1016/j.msard.2017.08.016
Labiano-Fontcuberta A, Aladro Y, Martínez-Ginés ML, Ayuso L, Mitchell AJ, Puertas V, Cerezo M, Higueras Y, Benito-León J. Psychiatric disturbances in radiologically isolated syndrome. J Psychiatr Res. 2015;68:309-315. https://doi.org/10.1016/j.jpsychires.2015.05.008
Burns MN, Nawacki E, Kwasny MJ, Pelletier D, Mohr DC. Do positive or negative stressful events predict the development of new brain lesions in people with multiple sclerosis? Psychol Med. 2014;44(2):349-359. https://doi.org/10.1017/S0033291713000755
Lebrun C, Bensa C, Debouverie M, De Seze J, Wiertlievski S, Brochet B, Clavelou P, Brassat D, Labauge P, Roullet E; CFSEP. Unexpected multiple sclerosis: Follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry. 2008;79(2):195-198. https://doi.org/10.1136/jnnp.2006.108274
Sviridova AA, Kabaeva AR, Rogovskii VS, Kozhieva MK, Melnikov MV, Boyko AN. Norepinephrine and intestinal microbiome in the early stages of demyelination: clinical-immunological parallels. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2019;119(10. Vyp. 2):28-34. (In Russ.). https://doi.org/10.17116/jnevro20191191028.
Okuda DT, Mowry EM, Cree BA, Crabtree EC, Goodin DS, Waubant E, Pelletier D. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology. 2011;76(8):686-692. https://doi.org/10.1212/WNL.0b013e31820d8b1d
Lebrun C, Bensa C, Debouverie M, Wiertlevski S, Brassat D, de Seze J, Rumbach L, Pelletier J, Labauge P, Brochet B, Tourbah A, Clavelou P; Club Francophone de la Sclérose en Plaques. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: Follow-up of 70 patients. Arch Neurol. 2009;66(7):841-846. https://doi.org/10.1001/archneurol.2009.119
Zeydan B, Gu X, Atkinson EJ, Keegan BM, Weinshenker BG, Tillema JM, Pelletier D, Azevedo CJ, Lebrun-Frenay C, Siva A, Okuda DT, Kantarci K, Kantarci OH. Cervical spinal cord atrophy: An early marker of progressive MS onset. Neurol Neuroimmunol Neuroinflamm. 2018;5(2):e435. https://doi.org/10.1212/NXI.0000000000000435
Bisulca J, De Lury A, Coyle PK, Syritsyna O, Peyster R, Bangiyev L, Duong TQ. MRI features associated with high likelihood of conversion of radiologically isolated syndrome to multiple sclerosis. Mult Scler Relat Disord. 2019;36:101381. https://doi.org/10.1016/j.msard.2019.101381
Mistry N, Abdel-Fahim R, Samaraweera A, Mougin O, Tallantyre E, Tench C, Jaspan T, Morris P, Morgan PS, Evangelou N. Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. Mult Scler. 2016;22(10):1289-1296. https://doi.org/10.1177/1352458515616700
Cortese R, Magnollay L, Tur C, Abdel-Aziz K, Jacob A, De Angelis F, Yiannakas MC, Prados F, Ourselin S, Yousry TA, Barkhof F, Ciccarelli O. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology. 2018;90(14):1183-1190. https://doi.org/10.1212/WNL.0000000000005256
Suthiphosuwan S, Sati P, Guenette M, Montalban X, Reich DS, Bharatha A, Oh J. The Central Vein Sign in Radiologically Isolated Syndrome. AJNR Am J Neuroradiol. 2019;40(5):776-783. https://doi.org/10.3174/ajnr.A6045
Azevedo CJ, Overton E, Khadka S, Buckley J, Liu S, Sampat M, Kantarci O, Lebrun Frenay C, Siva A, Okuda DT, Pelletier D. Early CNS neurodegeneration in radiologically isolated syndrome. Neurol Neuroimmunol Neuroinflamm. 2015;2(3):e102. https://doi.org/10.1212/NXI.0000000000000102
George IC, El Mendili MM, Inglese M, Azevedo CJ, Kantarci O, Lebrun C, Siva A, Okuda DT, Pelletier D. Cerebellar volume loss in radiologically isolated syndrome. Mult Scler. 2019;1352458519887346. https://doi.org/10.1177/1352458519887346
Wylezinska M, Cifelli A, Jezzard P, Palace J, Alecci M, Matthews PM. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology. 2003;60(12):1949-1954. https://doi.org/10.1212/01.wnl.0000069464.22267.95
Henry RG, Shieh M, Okuda DT, Evangelista A, Gorno-Tempini ML, Pelletier D. Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry. 2008;79(11):1236-1244. https://doi.org/10.1136/jnnp.2007.134825
Aubert-Broche B, Fonov V, Ghassemi R, Narayanan S, Arnold DL, Banwell B, Sled JG, Collins DL. Regional brain atrophy in children with multiple sclerosis. Neuroimage. 2011;58(2):409-415. https://doi.org/10.1016/j.neuroimage.2011.03.025
Calabrese M, Mattisi I, Rinaldi F, Favaretto A, Atzori M, Bernardi V, Barachino L, Romualdi C, Rinaldi L, Perini P, Gallo P. Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2010;81(4):401-404. https://doi.org/10.1136/jnnp.2009.177733
Rocca MA, Preziosa P, Mesaros S, Pagani E, Dackovic J, Stosic-Opincal T, Drulovic J, Filippi M. Clinically isolated syndrome suggestive of multiple sclerosis: Dynamic patterns of gray and white matter changes — A 2-year MR imaging study. Radiology. 2016;278(3):841-853. https://doi.org/10.1148/radiol.2015150532
Giorgio A, Stromillo ML, Rossi F, Battaglini M, Hakiki B, Portaccio E, Federico A, Amato MP, De Stefano N. Cortical lesions in radiologically isolated syndrome. Neurology. 2011;77(21):1896-1899. https://doi.org/10.1212/WNL.0b013e318238ee9b
Giorgio A, Stromillo ML, De Leucio A, Rossi F, Brandes I, Hakiki B, Portaccio E, Amato MP, De Stefano N. Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures. J Neurosci. 2015;35(2):550-558. https://doi.org/10.1523/JNEUROSCI.2557-14.2015
Stromillo ML, Giorgio A, Rossi F, Battaglini M, Hakiki B, Malentacchi G, Santangelo M, Gasperini C, Bartolozzi ML, Portaccio E, Amato MP, De Stefano N. Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. Neurology. 2013;80(23):2090-2094. https://doi.org/10.1212/WNL.0b013e318295d707
Knier B, Berthele A, Buck D, Schmidt P, Zimmer C, Mühlau M, Hemmer B, Korn T. Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination. Mult Scler. 2016;22(7):893-900. https://doi.org/10.1177/1352458515604496
Vural A, Okar S, Kurne A, Sayat-Gürel G, Acar NP, Karabulut E, Oğuz KK, Kadayıfçılar S, Karabudak R. Retinal degeneration is associated with brain volume reduction and prognosis in radiologically isolated syndrome. Mult Scler. 2020;26(1):38-47. https://doi.org/10.1177/1352458518817987
Makhani N, Lebrun C, Siva A, Narula S, Wassmer E, Brassat D, Brenton JN, Cabre P, Carra Dallière C, de Seze J, Durand Dubief F, Inglese M, Langille M, Mathey G, Neuteboom RF, Pelletier J, Pohl D, Reich DS, Ignacio Rojas J, Shabanova V, Shapiro ED, Stone RT, Tenembaum S, Tintoré M, Uygunoglu U, Vargas W, Venkateswaren S, Vermersch P, Kantarci O, Okuda DT, Pelletier D; Observatoire Francophone de la Sclérose en Plaques (OFSEP), Société Francophone de la Sclérose en Plaques (SFSEP), the Radiologically Isolated Syndrome Consortium (RISC) and the Pediatric Radiologically Isolated Syndrome Consortium (PARIS). Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome. Mult Scler J Exp Transl Clin. 2019;5(1):2055217319836664. https://doi.org/10.1177/2055217319836664
Matute-Blanch C, Villar LM, Álvarez-Cermeño JC, Rejdak K, Evdoshenko E, Makshakov G, Nazarov V, Lapin S, Midaglia L, Vidal-Jordana A, Drulovic J, García-Merino A, Sánchez-López AJ, Havrdova E, Saiz A, Llufriu S, Alvarez-Lafuente R, Schroeder I, Zettl UK, Galimberti D, Ramió-Torrentà L, Robles R, Quintana E, Hegen H, Deisenhammer F, Río J, Tintoré M, Sánchez A, Montalban X, Comabella M. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome. Brain. 2018;141(4):1085-1093. https://doi.org/10.1093/brain/awy021
Boyko A. Radiologically isolated syndrome with oligoclonal bands in CSF (RIS + OCB) can be classified as high MS risk group. Mult Scler. 2019;1352458519879622. https://doi.org/10.1177/1352458519879622
Cantó E, Tintoré M, Villar LM, Costa C, Nurtdinov R, Álvarez-Cermeño JC, Arrambide G, Reverter F, Deisenhammer F, Hegen H, Khademi M, Olsson T, Tumani H, Rodríguez-Martín E, Piehl F, Bartos A, Zimova D, Kotoucova J, Kuhle J, Kappos L, García-Merino JA, Sánchez AJ, Saiz A, Blanco Y, Hintzen R, Jafari N, Brassat D, Lauda F, Roesler R, Rejdak K, Papuc E, de Andrés C, Rauch S, Khalil M, Enzinger C, Galimberti D, Scarpini E, Teunissen C, Sánchez A, Rovira A, Montalban X, Comabella M. Chitinase 3-like 1: Prognostic biomarker in clinically isolated syndromes. Brain. 2015;138(Pt 4):918-931. https://doi.org/10.1093/brain/awv017
Thouvenot E, Hinsinger G, Demattei C, Uygunoglu U, Castelnovo G, Pittion-Vouyovitch S, Okuda D, Kantarci O, Pelletier D, Lehmann S, Marin P, Siva A, Lebrun C. Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome. Mult Scler. 2019;25(5):669-677. https://doi.org/10.1177/1352458518767043
Pawlitzki M, Sweeney-Reed CM, Bittner D, Lux A, Vielhaber S, Schreiber S, Paul F, Neumann J. CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome — Sign of Inflammation. Front Neurol. 2018;9:1075. https://doi.org/10.3389/fneur.2018.01075
Rossi S, Motta C, Studer V, Macchiarulo G, Germani G, Finardi A, Furlan R, Martino G, Centonze D. Subclinical central inﬂammation is risk for RIS and CIS conversion to MS. Mult Scler. 2015;21(11):1443-1452. https://doi.org/10.1177/1352458514564482
Lebrun C, Cohen M, Pignolet B, Seitz-Polski B, Bucciarelli F, Benzaken S, Kantarci O, Siva A, Okuda D, Pelletier D, Brassat D; on behalf SFSEP, BIONAT Network; RISC. Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disorders. J Neurol Sci. 2016;368:334-336. https://doi.org/10.1016/j.jns.2016.07.052
Sehitoğlu E, Cavuş F, Ulusoy C, Küçükerden M, Orçen A, Akbaş-Demir D, Coban A, Vural B, Tüzün E, Türkoğlu R. Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study. Inflamm Res. 2014;63(10):799-801. https://doi.org/10.1007/s00011-014-0754-0